胃癌的基因治疗新进展
Advances in genother apy of gastric cancer
出处
《武警医学》
CAS
2004年第1期10-14,共5页
Medical Journal of the Chinese People's Armed Police Force
参考文献19
-
1Becher KP, Keller G, Hoefler H et al. The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol,2000,9(1) :5- 11.
-
2Tanjguchi K, Vonemura Y, Nojima Net ol. The relation between the growth patterns of gastric carcinoma and the expression of C - met, AMFR and u - PAR. Cancer, 1998,82( 11 ) :2 112- 2 122.
-
3Kaji M, Yonemura Y,Harada Set al. Participation of C - met in the progression of human gsstric carcinomas. Cancer Gene Ther, 1996,3(6) :393 - 404.
-
4Nakajima M, Sawada H, Yamada Yet al. The prognostic significance of amplification and over expression of' C - met and C- erbB - 2 in human gastric carcinoma. Cancer, 1999, 85(6): 1 894- 1 902.
-
5Koyatrm S, Maruyatrm T, Aolachi Set al. Expression of epidermal growth factor receptor and CD 44 splicing variants sharing exon 6 and 9 on gastric and esophageal carcinoma : a two color flow cytometric analysis. J Cancer Res Clin Oncol, 1999, 125(1) :47 -54.
-
6Onoda N, Maeda K, Chung YS et al. Over expression of C -myc messenger RNA primary and metastatic lesions of carcinoma of the stomach. J Am Cell Surg, 1996,182( 1 ) : 55 - 59.
-
7Yamamoto T. Detection of C - myc oncogene product on human gastric carcinoma. Jpn J Cancer Res, 1987,78:11 -69.
-
8Ogawa M, Maeda K, Onoda N et al. Loss of p21expression correlates with disease progression in gastric carcinoma. Bri J Cancer, 1997,75(11) : 1 617 - 1 620.
-
9Noda H, Maeham Y, Irie K et al. Increased proliferative activity caused by loss p21 expression and its clinical significance in patients with early stage gastric carcinoma. Cancer, 2002,94(7) :2 107- 2 112.
-
10Tsujie M, Yamarnoto H, Tomita Net al. Expression of tumor suppressor gene p16 products in primary, gastric cancer. Oncology,2000,58(2) : 126 - 136.
-
1沈周俊.肾癌的基因治疗[J].杭州医学高等专科学校学报,2004,25(4):157-158.
-
2傅震,王存祖.脑胶质瘤中pRB及其相关基因的异常表达[J].江苏医药,2000,26(5):360-362.
-
3石彦,余佩武.胃癌基因治疗的现状和进展[J].中华胃肠外科杂志,2002,5(4):306-308.
-
4张延龄.胰腺癌的基因治疗研究[J].临床外科杂志,2004,12(4):242-243. 被引量：3
-
5计骏,张俊,于颖彦,陈国庭,刘炳亚,朱正纲,尹浩然,林言箴.KAI1基因在胃癌组织的表达及其与临床病理因素的关系[J].中华实验外科杂志,2004,21(9):1147-1147. 被引量：3
-
6尚超,张佳星,陈秀秀,张家乐,黄宝俊.RGCC基因在胃癌组织中的表达及其意义[J].山东医药,2016,56(16):77-79. 被引量：2
-
7研究人员发现新的突变基因[J].英国医学杂志中文版,1999,2(3):109-109.
-
8仇容,司马军,范兴丽.结直肠癌组织缺陷基因的杂合性缺失及其意义[J].肿瘤防治杂志,2005,12(11):833-835.
-
9秦新裕,刘凤林.胃癌外科研究进展[J].中华实验外科杂志,2009,26(7):823-824. 被引量：8
-
10诸葛春凤,刘诗权.上皮-间质转化在结直肠癌中的研究进展[J].胃肠病学,2016,21(5):307-310. 被引量：3
